Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AFL OTCMKTS:CBDS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFLAflac$109.41+1.7%$104.29$96.95▼$115.50$58.50B0.852.21 million shs1.25 million shsCBDSCannabis Sativa$0.03-0.6%$0.04$0.00▼$0.17N/AN/A1.07 million shs2.36 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFLAflac-0.66%+1.25%+2.12%+4.90%-2.35%CBDSCannabis Sativa-0.58%+10.22%-8.12%+7.81%+666.67%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFLAflac$109.41+1.7%$104.29$96.95▼$115.50$58.50B0.852.21 million shs1.25 million shsCBDSCannabis Sativa$0.03-0.6%$0.04$0.00▼$0.17N/AN/A1.07 million shs2.36 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFLAflac-0.66%+1.25%+2.12%+4.90%-2.35%CBDSCannabis Sativa-0.58%+10.22%-8.12%+7.81%+666.67%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFLAflac 2.08Hold$109.15-0.24% DownsideCBDSCannabis Sativa 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CBDS, XAF, AFL, and AHX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/18/2025AFLAflacMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$108.00 ➝ $113.008/14/2025AFLAflacEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingUnderperform$105.00 ➝ $106.008/11/2025AFLAflacWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$105.00 ➝ $107.008/11/2025AFLAflacKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Perform$106.00 ➝ $108.008/6/2025AFLAflacUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$114.00 ➝ $111.007/10/2025AFLAflacWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$103.00 ➝ $105.007/8/2025AFLAflacJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$96.00 ➝ $100.007/7/2025AFLAflacBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetUnderweight$96.00 ➝ $98.00(Data available from 9/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFLAflac$18.93B3.09$8.95 per share12.23$46.98 per share2.33CBDSCannabis SativaN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFLAflac$5.44B$4.4124.8015.133.0315.32%15.08%3.21%10/29/2025 (Estimated)CBDSCannabis SativaN/A-$0.05N/A∞N/AN/AN/AN/AN/ALatest CBDS, XAF, AFL, and AHX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025AFLAflac$1.71$1.78+$0.07$1.11$4.30 billion$4.16 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFLAflac$2.322.12%N/A52.61%44 YearsCBDSCannabis SativaN/AN/AN/AN/AN/ALatest CBDS, XAF, AFL, and AHX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/5/2025AFLAflacquarterly$0.582.34%8/20/20258/20/20259/2/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFLAflac0.330.110.11CBDSCannabis SativaN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFLAflac67.44%CBDSCannabis SativaN/AInsider OwnershipCompanyInsider OwnershipAFLAflac0.80%CBDSCannabis Sativa27.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFLAflac12,694534.83 million530.55 millionOptionableCBDSCannabis Sativa1N/AN/ANot OptionableCBDS, XAF, AFL, and AHX HeadlinesRecent News About These CompaniesUNLV students innovate to look into underreported impacts of cannabisSeptember 10, 2025 | thenevadaindependent.comTDogecoin Cash, Inc. Subsidiary PrestoDoctor Now Accepts Cryptocurrency Payments, Including DogecoinSeptember 10, 2025 | globenewswire.comGlobal Cannabidiol (CBD) Market to grow at 16% CAGR, driven by legalization & wellness trends 2029September 9, 2025 | pharmiweb.comPTHC ban burns out in Texas as special session ends. Is marijuana legal now? What to knowSeptember 4, 2025 | msn.comHemp-Derived Products vs. Medical Marijuana: Legal Distinctions in FloridaSeptember 3, 2025 | southfloridareporter.comSCalifornia Cannabis Testing Labs Provides A Closer Look at Cannabis StrainsAugust 28, 2025 | sfexaminer.comSCannabidiol shows potential to reverse some neuropsychological effects of social stressAugust 24, 2025 | msn.comStudy Explores the Effectiveness of Oil-Based Extraction MethodsAugust 23, 2025 | labroots.comLCBD Cream: A Potential Solution to Topical Pain and IrritationAugust 22, 2025 | qconline.comQHave THC laws changed in Texas? Here's a 2025 guide marijuana laws hemp, CBDAugust 20, 2025 | statesman.comSCannabis Sativa Beyond Contraband: Unlocking Its Scientific, Medical, and Agro-Industrial PotentialsAugust 19, 2025 | kashmirreader.comKTruckin’ To 2030: Europe’s Green Horizon For Medical Cannabis & HempAugust 12, 2025 | forbes.comStudy: Morocco’s Local ‘Beldiya’ Cannabis Variety Shows Superior StabilityAugust 9, 2025 | moroccoworldnews.comMDogecoin Cash, Inc. Announces PrestoDoctor's Expansion into Three New MarketsAugust 5, 2025 | globenewswire.comGummies for ED: Do they work?July 29, 2025 | msn.comDogecoin Cash Inc. Confirms Filing of Provisional Patent for Dogecoin Protocol FrameworkJuly 28, 2025 | globenewswire.comResearchers find reduced doses of CBD may cause liver harmJuly 27, 2025 | jang.com.pkJHow light and hormones shape cannabis flowersJuly 26, 2025 | alphagalileo.orgAIs THC legal in Texas? A 2025 guide to hemp, CBD and marijuana laws amid special sessionJuly 23, 2025 | msn.comTHC variant marketed as 'harmless' is worrying public health experts due to its popularityJuly 21, 2025 | earth.comENew MarketBeat Followers Over TimeMedia Sentiment Over TimeCBDS, XAF, AFL, and AHX Company DescriptionsAflac NYSE:AFL$109.33 +1.70 (+1.58%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.Cannabis Sativa OTCMKTS:CBDS$0.03 0.00 (-0.58%) As of 09/15/2025Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Hits Record High After CEO Hock Tan AI Pay Package CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors Resideo Technologies: Institutional Activity Signals 30% Upside This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge Rezolute Stock: FDA Fast Track Fuels 2025 Breakout Lululemon’s Sell-Off Looks Overdone: A Contrarian Case This Defense Stock Is Up 113% This Year—Is It Still a Buy? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
